Parker domnick hunter launches new PROPOR MR for faster removal of mycoplasma from cell culture media


Durham, UK, October 3, 2012, A new mycoplasma retentive filter for the biopharmaceutical industry has been launched by Parker domnick hunter.  The PROPOR MR speeds up processing of cell culture media, promising the fastest filtration times available without compromising on mycoplasma retention assurance. 

Mycoplasma species are common contaminants of cell culture media with the added problem that their small size and deformability gives them the ability to penetrate the 0.2 micron membranes used for sterilizing liquids.  For this reason, 0.1 micron filtration has been widely adopted for the filtration of cell culture media; however the higher retention comes at the price of slower flow rates, longer processing times and increased risk of contamination.

“PROPOR MR has been designed in direct response to a market need for faster processing of cell culture media,” said Andrew Kelly, Life Sciences Product Manager at Parker domnick hunter Process Filtration.  “Our customers have found that the highly retentive filters used for mycoplasma removal can slow down their process to the point that filtration cannot be achieved within the required time frame. This can significantly increase the risk and potential impact of contamination in the unfiltered cell culture media.” 

Parker domnick hunter have developed the PROPOR MR in close collaboration with customers using their actual cell culture media feed streams.  The result is a highly retentive filter (typically LRV>10 for Acholeplasma laidlawii ) with the fastest processing times for qualified mycoplasma retentive filtration.  In addition, an integral prefilter layer maximizes filtration capacity for reduced filter system sizes

The PROPOR MR launch follows the announcement of Parker’s acquisition of Madison based SciLog Inc , provider of automated solutions, and innovative sensor technology and will significantly strengthen Parker domnick hunter’s offering around upstream bioprocessing.  PROPOR MR will be available from October 2012.

About Parker Hannifin Corporation

With annual sales exceeding $13 billion in fiscal year 2012, Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies and systems, providing precision-engineered solutions for a wide variety of mobile, industrial and aerospace markets. The company employs approximately 60,000 people in 48 countries around the world. Parker has increased its annual dividends paid to shareholders for 56 consecutive fiscal years, among the top five longest-running dividend-increase records in the S&P 500 index. For more information, visit the company's web site at www.parker.com , or its investor information web site at www.phstock.com .

###

Contact information:
Andrew Kelly
Product Manager (Life Sciences)
Parker domnick hunter Process Filtration
andrew.kelly@parker.com  
+44 (0)191 301 4189
 
Issued by:

Pinnacle Marketing Communications Ltd,
Green Park House, 15 Stratton Street, London, W1J 8LQ
Tel: +44 (0) 20 8869 9339                 Fax: +44 (0) 20 8868 4373
Web: www.pinnacle-marketing.com
E-mail: s.krelle@pinnaclemarcom.com

About Us

About Parker Hannifin With annual sales exceeding $12 billion in fiscal year 2011, Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies and systems, providing precision-engineered solutions for a wide variety of mobile, industrial and aerospace markets. The company employs approximately 58,000 people in 47 countries around the world. Parker has increased its annual dividends paid to shareholders for 55 consecutive fiscal years, among the top five longest-running dividend-increase records in the S&P 500 index. For more information, visit the company's web site at www.parker.com, or its investor information web site at www.phstock.com.